PerkinElmer Wins Life Science Industry Award for High Throughput Screening
News May 31, 2007
PerkinElmer, Inc. took top honors for High Throughput Screening (HTS) in the 2007 Life Science Industry Awards, a special customer recognition honoring best-in-class suppliers in the life sciences.
Over 3,000 scientists from around the world participated in this independent survey, casting votes for the companies that have made the greatest contributions to life science technology in the past year.
"It is a tremendous honor to be recognized as best-in-class by the scientific community and our customers, and we are thankful that our technologies can help contribute to the important work these researchers are doing every day," said Robert F. Friel, President, PerkinElmer Life and Analytical Sciences.
"Whether it is our biochemical screening and cellular imaging instruments or our highly sensitive reagents and assay platforms, this award shows that the life sciences community has come to rely on PerkinElmer as the supplier of choice to provide the leading-edge technologies essential to advanced cellular research and drug discovery," Freil continued.
"PerkinElmer was named the winner of this category thanks in part to their success in redefining the category from one that encompasses only microplates to one that considers fully integrated, powerful platforms for drug discovery," commented Robin Rothrock, Ph.D., Director of Market Research at BioInformatics, LLC, the independent research firm that conducted the customer survey.
PerkinElmer offers a comprehensive portfolio of powerful HTS technologies, including automation, liquid handling, detection instruments, reagents as well as biochemical and cell-based assay platforms designed to deliver maximum versatility, high sensitivity and speed for laboratory screening needs.
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE